Cefaléia Associada aos Ciclos Hormonais da Mulher

Autores

  • Rafaela Larsen Ribeiro Médica Pós-graduanda da Disciplina de Medicina Interna e Terapêutica da Escola Paulista de Medicina – Unifesp.
  • Deusvenir de Souza Carvalho Professor-adjunto e Chefe do Setor de Investigação e Tratamento das Cefaléias da Disciplina de Neurologia, Escola Paulista de Medicina – Unifesp.

DOI:

https://doi.org/10.34024/rnc.2000.v8.8936

Palavras-chave:

Migrânea menstrual, fisiopatologia, tratamento

Resumo

Os ciclos normais da vida da mulher estão associados a marcadores hormonais: menarca, ovulação, gravidez, amamentação, uso de contraceptivos, menopausa e terapia de reposição hormonal. Esses eventos e intervenções alteram os níveis e ciclos dos hormônios sexuais e podem causar mudança na prevalência ou intensidade das cefaléias. Cefaléias que acompanham a síndrome pré-menstrual parecem ser geradas centralmente, envolvendo o sistema nervoso central, incluindo os sistemas serotoninérgicos moduladores de dor. As medicações específicas para migrânea, como os triptanos, podem ser efetivas para o tratamento agudo da migrânea menstrual. Entretanto, é importante reconhecer as relações entre a migrânea e o ciclo menstrual, porque a cefaléIa pode não responder aos tratamentos antimigranosos usuais.

Downloads

Não há dados estatísticos.

Referências

Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. JAMA, 267:64-9, 1992.

Massiou H, Bousser MG. Influence of hormones on migrane. In: Olesen J, Tfelt-Hansen P, Welch KMA (eds.). The Headaches. Philadelphia, Lippincott Williams & Wilkins, 2000, p. 261-7.

Epstein MT, Hockaday JM, Hockaday TDR. Migraine and reproductive hormones throughout the menstrual cycle. Lancet, 1:543-8, 1975.

Macgregor A. Migraine in women. London, Martin Dunitz, 1999. p. 90.

Singh I, Singh D. Progesterone in the treatment of migraine. Lancet, 1:745, 1947.

Greene R, Dalton KD. The premenstrual syndrome. Brit Med J, 1:1007, 1953.

Dalton KD. Progesterone suppositories and pessaries in the treatment of menstrual migraine. Headache, 12: 150-8, 1973.

Somerville BW. The role of oestradiol withdrawal in the etiology of menstrual migraine. Neurology, 22:355-65, 1972.

Welch KMA, Darnely D, Simkings RT. The role of estrogen in migraine: a review and a hypothesis. Cephalalgia, 4:227-36, 1984.

DiCarlo C, Bifulco G, Pellicano M, Napolitano V, Nappi C. Hormonal treatment of premenstrual syndrome. Cephalalgia, 17(suppl. 20):17-9, 1997.

Fioroni L, Martignoni E, Facchinetti F. Changes of neuroendocrine axes in patients with menstrual migraine. Cephalalgia, 15:297-300, 1995.

Benedetto C, Allais G, Ciochetto D, DeLorenzo C. Pathopysiological aspects of menstrual migraine. Cephalalgia, 17(suppl. 20):2-4, 1997.

Carlson LA, Ekelund LG, Oro L. Clinical and metabolic effects of different doses of prostaglandin E in man. Acta Med Scand, 183:423-30, 1968.

Nattero G, Allais G, DeLorenzo C, Torre E, Ancona M, Benedetto C, Massobrio M. Menstrual migraine: new biochemical and psychological aspects. Headache, 28:103-7, 1988.

Nattero G, Allais G, DeLorenzo C, Benedetto C, Zonca M, Melzi E, Massobrio M. Relevance of prostaglandins in true menstrual migraine. Headache, 29:233-8, 1989.

Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache, 30:705-9, 1990.

Benedetto C, Massobrio M, Zonca M. Menstrual migraine: a possible pathogenic implication of platelet function. Gynecol Endocrinol, 1:345-53, 1987.

Leira R, Martinez F, Castillo J, Rodriguez JR, Lema M, Noya M. Hormonal profile and changes in platelet aggregation in menstrual migraine. Neurologia, 5:306-9, 1990.

Taylor DL, Mathew RJ, Ho BT, Weinamn ML. Serotonin levels and platelet uptake during prementrual tension. Neuropsychobiology, 12:16-8, 1984.

Rapkin AJ, Edelmuth E, Chang LC, Reading AE, McGuire MT, Su TP. Whole blood serotonin in premenstrual syndrome. Obstet Gynecol, 70:533-7, 1987.

Silberstein SD, Merriam GR. Estrogens, progestins and headache. Neurology, 41:786-93, 1991.

D’Andrea G, Hasselmark L, Cananzi AR, Alecci M, Perini F, Zamberlan F, Welch KMA. Metabolism and menstrual cycle rhytmicity of serotonin in primary headaches. Headache, 35:216-21, 1995.

Allais G, Facco G, Ciochetto D, DeLorenzo C, Piore M, Benedetto C. Patterns of platelet aggregation in menstrual migraine. Cephalalgia, 17(suppl. 20):39-41, 1997.

Fioroni L, D’Andrea G, Alecci M, Cananzi A, Facchinetti F. Platelet serotonin pathway in menstrual migraine. Cephalalgia, 16:427-30, 1996.

Facchinetti F, Nappi G, Petraglia F, Volpe A, Genazzani AR. Oestradiol/progesterone inbalance and the premenstrual syndrome. Lancet 1983; ii:1302.

Ghose K, turner P. The menstrual cycle and tyramine pressor response test. Br J Clin Pharmacol, 4:500-2, 1977.

Magos AL, Brincat M, Zikha EJ, Studd JWW. Serum dopamineb-hydroxilase activity in mesntraul migraine. J Neurol Neurosurg Psychiatry, 48:328-31, 1985.

Jones SB, Bylund DB, Rieser CA, Shekim WO, Byer JA, Carr GW. α-2-adrenergic receptor binding in human platelets: alterations during the menstrual cycle. Clin Pharmacol Ther, 34:90-6, 1983.

Facchinetti F, Martignoni E, Nappi G, Fioroni L, Sances G, Genazzani AR. Premenstrual failure of α-adrenergic stimulation on hypothalamus-pituitary responses in menstrual migraine. Psychosom Med, 51:550-8, 1969.

Murialdo G, Fonzi S, Costelli P, Solinas GP, Parodi C, Marabini S. Urinary melatonin excretion though out the ovarian cycle in menstrual related migrane. Cephalalgia, 14:205-9, 1994.

Awaki E, Takeshima T, Takahashi K. A neuroendocrinological study in female migraneurs: prolactin and thyroid stimulting hormone responses. Cephalalgia, 9:187-93, 1989.

Consenso da Sociedade Brasileira de Cefaléia. Recomendações para o tratamento da crise migranosa. Arq Neuropsiquiatr, 58(2-A):371-89, 2000.

Pfaffenrath, V. Efficacy and safety of percutaneous estradiol vs placebo in menstrual migrane. Cephalalgia, 13 (suppl. 13):244, 1993.

Steiner M, Steinberg S, Stewart D et al. Fluoxetin in the treatment of premenstrual dysphoria. N Engl J Med, 332:1529-34, 1995.

Facchinetti F, Bonellie G, Kangasniemi P, Pascual J, Shuaib A. The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migrane. Obstet Gynecol, 86:911-6, 1995.

Murray SC, Muse KN. Effective treatment of severe menstrual migraine headaches with gonadotropin-realising hormone agonist and “add-back” therapy. Fertil Steril, 67(2):390-3, 1997.

Newman LC, Lipton RB, Lay CL, Solomon S. A pilot study of oral sumatriptan as intermitent prophylaxis of menstruationrelated migrane. Neurology, 51:307-9, 1998.

Grunfeld E, Gresty MA. Relationship between motion sickness, migrane and menstruation in crew members of a “round the world” yacht race. Brain Research Bull, 47(5):433-6, 1998.

Silberstein SD, Armellino JJ, Hoffman HD, Battikha JP, Hamelsky SW, Stewart WF, Lipton RB. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies. Clin Ther, 21(3):475-91, 1999.

Downloads

Publicado

2000-09-30

Como Citar

Ribeiro, R. L., & Carvalho, D. de S. (2000). Cefaléia Associada aos Ciclos Hormonais da Mulher. Revista Neurociências, 8(3), 93–98. https://doi.org/10.34024/rnc.2000.v8.8936

Edição

Seção

Artigos Originais
Recebido em 2019-02-01
Publicado em 2000-09-30

Artigos mais lidos pelo mesmo(s) autor(es)